• Switzerland suspends certain bonuses of Credit Suisse bankers after the absorption by UBS.
  • UBS is entering talks with Klein to end the First Boston deal.
  • Zuckerberg and Meta Platforms are sued for failing to fight human trafficking and child exploitation.
  • Fujitsu General falls on the stock market after Sweden's Nibe Industrier drops its bid to buy the company.
  • Alphabet launches public access to Bard, a rival to ChatGPT.
  • SUSE makes a surprise boss change, with Dirk-Peter van Leeuwen joining to replace Melissa Di Donato.
  • Pierer Mobility extends the CEO's contract and appoints a new CFO.
  • Kuehne + Nagel and Decathlon expand their collaboration in Latin America.
  • Sandoz (Novartis) receives US FDA approval for biosimilar Hyrimoz Injection.
  • Nike warned on Tuesday that its margins were under pressure due to heavy promotions to reduce excess inventory. The announcement offset an upward revision of annual revenue guidance after better-than-expected fourth-quarter sales.
  • First republic Bank was down 9% in premarket trading on concerns about the troubled bank's ability to secure a capital injection. US authorities are considering a possible government bailout to help the group cope with unrealized losses, according to a Bloomberg report.
  • Boeing fell 1.34% in pre-market trading due to additional charges for the KC-46 tanker program. 
  • Gamestop, whose stock is popular with retail investors, climbed nearly 40 percent in pre-market trading as the video game distributor reported its first quarterly profit in two years.
  • Virgin Orbit, billionaire Richard Branson's troubled aerospace company, is set to secure a $200 million investment from private equity firm Matthew Brown Companies via a private placement of shares, according to a document seen by Reuters. 
  • Eli Lilly will partner with Roche to develop a blood test for Alzheimer's disease.
  • Finnish video game maker Rovio, which publishes the Angry Birds game, has ended its takeover talks with Playtika.
  • Regeneron said on Wednesday that the US Food and Drug Administration (FDA) had approved the extension of its cholesterol treatment to children aged 5 to 11.

Main earnings reports today: Tencent, Wuxi Biologics, Raymond James, Chewy, Terna, Jeronimo Martins, Vistry... The whole agenda is here.